Latest Breaking News On - Praxis precision medicines inc - Page 4 : comparemela.com

Praxis Precision Medicines (NASDAQ:PRAX) Now Covered by Analysts at Robert W Baird

Praxis Precision Medicines (NASDAQ:PRAX) Now Covered by Analysts at Robert W Baird
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Robertw bairdConnor clark lunn investment management ltdPraxis precision medicines incJefferies financial groupSimplex tradingYork mellon corpCitigroup incJump financialPraxis precision medicinesFree reportFinancial groupModerate buyPrecision medicinesGet free reportPraxis precisionLunn investment management

Short Interest in Praxis Precision Medicines, Inc (NASDAQ:PRAX) Expands By 77 1%

Short Interest in Praxis Precision Medicines, Inc (NASDAQ:PRAX) Expands By 77 1%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Windmill hill asset management ltdJefferies financial groupWealth advisorsVictory capital management incSimplex tradingPraxis precision medicines incPraxis precision medicinesGet free reportCapital managementHill asset management ltdPrecision medicinesPraxis precision medicines daily

HC Wainwright Reiterates Buy Rating for Praxis Precision Medicines (NASDAQ:PRAX)

Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a research note issued on Friday, Benzinga reports. They presently have a $105.00 price objective on the stock. HC Wainwright’s target price indicates a potential upside of 91.61% from the company’s previous close. PRAX […]

Connor clark lunn investment management ltdPraxis precision medicines incAsset management incJefferies financial groupSilverarc capital managementJump financialYork mellon corpPraxis precision medicinesGet free reportFinancial groupPrecision medicinesPraxis precisionNew york mellon corpManagement incCapital managementConnor clark

Praxis Precision Medicines (PRAX) Buy Rating Reaffirmed at HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Praxis Precision Medicines (NASDAQ:PRAX – Free Report) in a research note issued to investors on Friday morning, Benzinga reports. They currently have a $105.00 price objective on the stock. Other analysts have also issued reports about the company. Wedbush boosted their price objective on Praxis Precision […]

Acuta capital partnersPraxis precision medicines incCitigroup incSilverarc capital managementJefferies financial groupAsset management incPraxis precision medicinesFree reportFinancial groupPrecision medicinesGet free reportCapital partnersCapital managementManagement incPraxis precision medicines dailyNasdaq prax

HC Wainwright Reiterates Buy Rating for Praxis Precision Medicines (NASDAQ:PRAX)

Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report)‘s stock had its “buy” rating reissued by analysts at HC Wainwright in a research note issued to investors on Friday, Benzinga reports. They presently have a $105.00 target price on the stock. HC Wainwright’s target price would indicate a potential upside of 98.56% from the company’s previous […]

Praxis precision medicines incCitigroup incJefferies financial groupAcuta capital partnersConnor clark lunn investment management ltdPraxis precision medicinesGet free reportFinancial groupPrecision medicinesCapital partnersLunn investment managementPraxis precision medicines dailyNasdaq praxReiterated ratingHc wainwright